Orthocell receives $2.9 million R&D refund

Nerve technology developer Orthocell (ASX:OCC) has received a $2.9 million R&D tax incentive refund for the 2018/19 financial year. The Perth company, which is commercialising its CelGro product to facilitate the regeneration of severed peripheral nerves, will invest the funds to accelerate regulatory approvals and to advance R&D. The company also recently raised new capital…

Australian Vanadium in talks with Chinese steelmaker

Resources and chemicals group Australian Vanadium (ASX: AVL) has signed an agreement which could see its services and products sold into the China market. The company, which is developing large-scale vanadium deposits and manufactures vanadium battery electrolyte, signed agreements with Hebei Yanshan Vanadium and Titanium Industry Technology Research Co to allow the negotiation of a…